Keller, Malene B.
Sørensen, Trine H.
Krogh, Kristian B. R. M.
Wogulis, Mark
Borch, Kim
Westh, Peter http://orcid.org/0000-0002-6185-0637
Funding for this research was provided by:
Novo Nordisk Fonden (NNF15OC0016606, NNFSA170028392)
Innovationsfonden (7043-00016B, 5150‐00020B)
Carlsbergfondet
Article History
Received: 6 May 2020
Accepted: 4 July 2020
First Online: 10 July 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The authors declare the following conflicts of interest: Kim Borch, Trine H. Sørensen, Kristian B. R. M. Krogh, and Mark Wogulis work for Novozymes A/S, a major manufacturer of industrial enzymes.